Meeting
2023 ASCO Annual Meeting
Treatments and clinical outcomes in stage II colon cancer (CC) patients (pts) with 12-gene Oncotype DX Colon Recurrence Score assay-guided therapy: Real-world data.
Authors
Baruch Brenner
Rabin Medical Center, Petah Tikva, Israel
Baruch Brenner , Yakatherina Shulman , Ayala Hubert , Sofia Man , Ravit Geva , Irit Ben-Aharon , Shlomit Fennig , Moshe Mishaeli , Nirit Yarom , Gil Bar-Sela , Ronen Brenner , Ayelet Shay , Lior Soussan-Gutman , Hillary Voet , Avital Bareket-Samish , Nicky Liebermann
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal Cancer—Colorectal and Anal
Track
Gastrointestinal Cancer—Colorectal and Anal
Sub Track
Colorectal Cancer–Local-Regional Disease
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 3620)
DOI
10.1200/JCO.2023.41.16_suppl.3620
Abstract #
3620
Poster Bd #
320
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Annual Meeting
Clinical outcomes and impact of mismatch repair deficiency (dMMR) in patients with pT4N0 colon cancer (CC): Data from a large, consecutive, multicenter, real-world cohort.
First Author: Alberto Puccini
Poster
2018 Gastrointestinal Cancers Symposium
The 12-gene Oncotype DX Colon Recurrence Score (RS) test: Experience with > 20,000 stage 2 patients (pts).
First Author: Helen Bailey
Poster
2013 Gastrointestinal Cancers Symposium
Prediction of clinical outcome in stage II and III colon cancer by a common gene variant in AXIN2.
First Author: Joanna Szkandera
Poster
2012 Gastrointestinal Cancers Symposium
Evaluation of the prognostic value of guanylyl cyclase C (GCC) lymph node (LN) classification in patients with stage II colon cancer: A pooled analysis.
First Author: Daniel J. Sargent